7.94
price up icon2.98%   0.23
after-market Handel nachbörslich: 7.94
loading
Schlusskurs vom Vortag:
$7.71
Offen:
$7.62
24-Stunden-Volumen:
325.79K
Relative Volume:
2.20
Marktkapitalisierung:
$297.02M
Einnahmen:
$128.45M
Nettoeinkommen (Verlust:
$6.54M
KGV:
158.80
EPS:
0.05
Netto-Cashflow:
$-8.79M
1W Leistung:
+4.20%
1M Leistung:
+7.15%
6M Leistung:
+36.43%
1J Leistung:
+88.15%
1-Tages-Spanne:
Value
$7.47
$8.69
1-Wochen-Bereich:
Value
$7.365
$8.69
52-Wochen-Spanne:
Value
$4.33
$8.85

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Name
Firmenname
Lifecore Biomedical Inc
Name
Telefon
(952) 368-4300
Name
Adresse
3515 LYMAN BOULEVARD, CHASKA
Name
Mitarbeiter
406
Name
Twitter
Name
Nächster Verdiensttermin
2025-04-03
Name
Neueste SEC-Einreichungen
Name
LFCR's Discussions on Twitter

Vergleichen Sie LFCR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
LFCR
Lifecore Biomedical Inc
7.94 279.06M 128.45M 6.54M -8.79M 0.05
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
153.20 67.75B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.29 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.84 43.70B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.48 21.51B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
380.47 18.31B 2.99B 1.21B 1.13B 25.06

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-21 Eingeleitet William Blair Outperform
2024-09-05 Eingeleitet Craig Hallum Buy
2024-08-28 Herabstufung Barrington Research Outperform → Mkt Perform
2023-03-20 Herabstufung Stephens Overweight → Equal-Weight

Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten

pulisher
Sep 03, 2025

What’s next for Lifecore Biomedical Inc. stock price2025 Short Interest & Accurate Buy Signal Notifications - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Detecting price anomalies in Lifecore Biomedical Inc. with AI2025 Geopolitical Influence & Fast Entry Momentum Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to monitor Lifecore Biomedical Inc. with trend dashboardsStop Loss & Long-Term Safe Investment Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Full technical analysis of Lifecore Biomedical Inc. stockJuly 2025 Momentum & Short-Term High Return Strategies - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Exit strategy if you’re trapped in Lifecore Biomedical Inc. - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Lifecore Biomedical Inc. stock recover after recent dropQuarterly Trade Report & AI Driven Stock Movement Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Should you wait for a breakout in Lifecore Biomedical Inc.Stop Loss & Growth Focused Stock Pick Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Lifecore Biomedical Inc. stock entering bullish territory2025 Major Catalysts & High Yield Equity Trading Tips - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Lifecore Biomedical Inc. stock chart pattern explainedWeekly Volume Report & Community Shared Stock Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Lifecore Biomedical to Participate in Upcoming Investor Conferences - GlobeNewswire

Sep 02, 2025
pulisher
Sep 02, 2025

What’s the beta of Lifecore Biomedical Inc. stockJuly 2025 Chart Watch & Real-Time Volume Triggers - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Lifecore Biomedical to Participate in Investor Conferences - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

CDMO Leader Lifecore Biomedical Announces Triple Conference Schedule Including Morgan Stanley Healthcare - Stock Titan

Sep 02, 2025
pulisher
Sep 02, 2025

Does Lifecore Biomedical Inc. stock benefit from AI growthJuly 2025 Update & Safe Capital Growth Stock Tips - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Published on: 2025-09-02 13:35:37 - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Detecting support and resistance levels for Lifecore Biomedical Inc.Dollar Strength & AI Powered Market Entry Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What to do if you’re stuck in Lifecore Biomedical Inc.Analyst Upgrade & Proven Capital Preservation Methods - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Sep 02, 2025
pulisher
Sep 02, 2025

What are the risks of holding Lifecore Biomedical Inc.July 2025 Weekly Recap & Entry Point Confirmation Signals - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Can a trend reversal in Lifecore Biomedical Inc. lead to recoveryMarket Performance Summary & Reliable Volume Spike Trade Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What are the future prospects of Lifecore Biomedical Inc.2025 Trading Recap & Stepwise Trade Signal Implementation - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Will Lifecore Biomedical Inc. benefit from seasonalityPortfolio Return Report & Trade Opportunity Analysis - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Is Lifecore Biomedical Inc. forming bullish engulfing patternsSell Signal & Consistent Profit Trade Alerts - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Using RSI to spot recovery in Lifecore Biomedical Inc.July 2025 Institutional & Long-Term Investment Growth Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Lifecore Biomedical’s (NASDAQ:LFCR) Undervaluation and Growth Potential: A Case for Strategic Investment - AInvest

Sep 01, 2025
pulisher
Sep 01, 2025

Using data models to predict Lifecore Biomedical Inc. stock movement2025 Performance Recap & Risk Managed Trade Strategies - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) Intrinsic Value Is Potentially 44% Above Its Share Price - Yahoo Finance

Sep 01, 2025
pulisher
Sep 01, 2025

Applying sector rotation models to Lifecore Biomedical Inc.Market Movers & Safe Entry Point Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

How hedge fund analytics apply to Lifecore Biomedical Inc. stockEntry Point & Stepwise Trade Signal Implementation - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Is Lifecore Biomedical Inc. forming a bullish divergenceWeekly Market Report & Stepwise Swing Trade Plans - kpenews.com

Aug 31, 2025
pulisher
Aug 31, 2025

Predicting Lifecore Biomedical Inc. trend using moving averages2025 Performance Recap & Technical Pattern Based Signals - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Relative strength of Lifecore Biomedical Inc. in sector analysisJuly 2025 Update & AI Powered Market Entry Strategies - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - ACCESS Newswire

Aug 31, 2025
pulisher
Aug 31, 2025

Automated trading signals detected on Lifecore Biomedical Inc.Trade Analysis Summary & Comprehensive Market Scan Insights - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Ranking Lifecore Biomedical Inc. among high performing stocks via toolsMarket Weekly Review & Weekly Top Stock Performers List - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

How sentiment analysis helps forecast Lifecore Biomedical Inc.Weekly Trade Analysis & Consistent Profit Trade Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Is Lifecore Biomedical Inc. stock ready for a breakoutJuly 2025 Action & Risk Controlled Swing Trade Alerts - Newser

Aug 30, 2025

Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Lifecore Biomedical Inc-Aktie (LFCR) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
English Aron R.
10% Owner
May 28 '25
Sale
7.12
150,419
1,071,555
264,180
English Aron R.
10% Owner
May 23 '25
Sale
6.75
96,137
649,386
1,554,103
English Aron R.
10% Owner
May 13 '25
Sale
7.00
12,334
86,353
1,650,240
English Aron R.
10% Owner
May 12 '25
Sale
7.03
45,698
321,426
1,662,574
English Aron R.
10% Owner
May 08 '25
Sale
7.00
5,098
35,693
1,708,972
English Aron R.
10% Owner
May 09 '25
Sale
7.00
700
4,900
1,708,272
English Aron R.
10% Owner
May 05 '25
Sale
7.08
24,543
173,831
1,730,618
English Aron R.
10% Owner
May 07 '25
Sale
7.01
15,847
111,099
1,714,070
English Aron R.
10% Owner
May 06 '25
Sale
7.05
701
4,940
1,729,917
Josephs Paul
Chief Executive Officer
Jan 08 '25
Buy
5.74
17,000
97,580
559,717
$28.92
price down icon 3.60%
$17.47
price up icon 0.69%
drug_manufacturers_specialty_generic RDY
$14.15
price down icon 0.28%
$10.33
price down icon 2.09%
$140.40
price up icon 3.15%
$380.47
price down icon 2.80%
Kapitalisierung:     |  Volumen (24h):